FealtySign in

HUMANA INC

(HUM)

CIK 49071 · SEC filings only

Not gradedDividend record
shown as history
company entity
15 dividend record entries

Dividend record — shown as history, not graded

A declared dividend is a reported fact, not a promise we grade. Here's the record — raises, holds, and cuts — each linked to its source filing.

Dividend record

15 declarations · 3 raised · 8 held · 0 cut · held 11 quarters

  1. HELD$0.8850/shperiod ended 2024-04-30Filing ↗
  2. HELD$0.8850/shperiod ended 2024-02-29Filing ↗
  3. HELD$0.8850/shperiod ended 2023-10-31Filing ↗
  4. HELD$0.8850/shperiod ended 2023-04-30Filing ↗
  5. RAISED$0.8850/shperiod ended 2023-02-28Filing ↗
  6. HELD$0.7900/shperiod ended 2022-10-31Filing ↗
  7. HELD$0.7875/shperiod ended 2022-04-30Filing ↗
  8. RAISED$0.7875/shperiod ended 2022-02-28Filing ↗
  9. HELD$0.7000/shperiod ended 2021-10-31Filing ↗
  10. HELD$0.7000/shperiod ended 2021-04-30Filing ↗
  11. RAISED$0.7000/shperiod ended 2021-02-28Filing ↗
  12. INITIATED$0.6250/shperiod ended 2020-11-30Filing ↗
Descriptive dividend record — every entry links to its source filing. Not graded (a declared dividend is a reported fact, not a promise). Full methodology →
FGuidance record
grade
company entity
8 resolved promises

Resolved promises

Pro

Full say-do history

Free scorecards show the 12 most recent resolved guidance promises. See the complete multi-year record with Pro.

See Pro →

Guidance shown, not graded (32)

These are non-GAAP forecasts. There is no comparable GAAP figure in SEC XBRL to check them against, so we show what was said — with its source filing — but never score it.

  1. eps guidance fy · Jul 29, 2026
    affirming its Adjusted EPS guidance of 'at least $9.00'
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  2. eps guidance fy · Apr 29, 2026
    affirming its Adjusted EPS guidance of 'at least $9.00'
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  3. eps guidance fy · Feb 11, 2026
    'at least $9.00' on an Adjusted basis
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  4. eps guidance fy · Nov 5, 2025
    affirms Adjusted FY 2025 EPS guidance of 'approximately $17.00'
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  5. eps guidance fy · Jul 30, 2025
    raises Adjusted FY 2025 EPS guidance to 'approximately $17.00'
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  6. eps guidance fy · Apr 30, 2025
    affirming its Adjusted EPS guidance of 'approximately $16.25'
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  7. eps guidance fy · Oct 30, 2024
    'at least $16.00' on an Adjusted basis
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  8. eps guidance fy · Jul 31, 2024
    affirming its Adjusted EPS guidance of approximately $16.00
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  9. eps guidance fy · Apr 24, 2024
    affirming its Adjusted EPS guidance of approximately $16.00
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  10. eps guidance fy · Jan 25, 2024
    'approximately $16.00' on an Adjusted basis
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  11. eps guidance fy · Nov 1, 2023
    affirms FY 2023 Adjusted EPS of 'at least $28.25'
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  12. eps guidance fy · Nov 1, 2023
    we remain committed to our 2025 Adjusted EPS target of $37
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  13. eps guidance fy · Aug 2, 2023
    we remain committed to our mid-term Adjusted EPS target of $37 in 2025
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  14. eps guidance fy · Aug 2, 2023
    affirms FY 2023 Adjusted EPS of 'at least $28.25'
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  15. eps guidance fy · Apr 26, 2023
    Adjusted EPS is expected to be 'at least $28.25'
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  16. eps guidance fy · Apr 26, 2023
    meeting our mid-term Adjusted EPS target of $37 in 2025
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  17. eps guidance fy · Feb 1, 2023
    we are confident in achieving our 2025 Adjusted EPS commitment of $37
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  18. eps guidance fy · Feb 1, 2023
    at least $28.00 on an Adjusted basis
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  19. eps guidance fy · Nov 2, 2022
    affirms recent $0.25 per share upward revision to Adjusted EPS guidance of 'approximately $25.00'
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  20. eps guidance fy · Nov 2, 2022
    achieving our new 2025 Adjusted EPS target of $37
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  21. eps guidance fy · Jul 27, 2022
    raises to 'approximately $24.75' on an Adjusted basis
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  22. eps guidance fy · Jul 27, 2022
    Updates FY 2022 EPS guidance to 'approximately $20.30' on a GAAP basis
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  23. eps guidance fy · Apr 27, 2022
    raises to 'approximately $24.50' on an Adjusted basis
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  24. eps guidance fy · Feb 2, 2022
    at least $24.00 on an Adjusted basis
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  25. eps guidance fy · Nov 3, 2021
    Humana is also revising its FY 2021 Adjusted EPS guidance to approximately $20.50
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  26. eps guidance fy · Jul 28, 2021
    maintains $21.25 to $21.75 on Adjusted basis
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  27. eps guidance fy · Apr 28, 2021
    Humana is maintaining its FY 2021 Adjusted EPS guidance range of $21.25 to $21.75
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  28. eps guidance fy · Feb 3, 2021
    $21.25 to $21.75
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  29. eps guidance q · Nov 3, 2020
    approximately $2.40 per share on an Adjusted basis
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  30. eps guidance fy · Nov 3, 2020
    Adjusted EPS in a range of $18.50 to $18.75
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  31. eps guidance fy · Aug 5, 2020
    Humana is maintaining its FY 2020 Adjusted EPS range of $18.25 to $18.75
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  32. eps guidance fy · May 2, 2018
    FY18 Adjusted EPS guidance was increased to $13.70 to $14.10
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗

Open promises (2) · 15 superseded

Open · eps guidance q

fourth quarter 2020 losses of approximately $2.55 per share on a GAAP basis

unresolved — no outcome on filereceipt →
Open · eps guidance fy

revising GAAP EPS guidance to 'at least $8.36'

resolves in ~198 daysreceipt →
Superseded · eps guidance fy

Humana is revising its GAAP EPS guidance range for the year ending December 31, 2021 (FY 2021) to $19.62 to $20.12

revised by a later guidancereceipt →
Superseded · eps guidance fy

GAAP $20.82 to $21.32

revised by a later guidancereceipt →
Superseded · eps guidance fy

Updates FY 2022 EPS guidance to 'approximately $22.98' on a GAAP basis

revised by a later guidance$22.9800receipt →
Superseded · eps guidance fy

FY 2020 GAAP EPS expected to be in a range of $17.36 to $17.86

revised by a later guidancereceipt →
Superseded · eps guidance fy

Announces initial FY 2024 EPS guidance of 'approximately $14.87' on a GAAP basis

revised by a later guidance$14.8700receipt →
Superseded · eps guidance fy

Humana introduces its GAAP EPS guidance for the year ending December 31, 2026 (FY 2026) of 'at least $8.89'

revised by a later guidancereceipt →
Superseded · eps guidance fy

Announces FY 2023 EPS guidance of at least $27.57 on a GAAP basis

revised by a later guidancereceipt →
Superseded · eps guidance fy

at least $23.08 on a GAAP basis

revised by a later guidancereceipt →
Superseded · eps guidance fy

Humana revised its GAAP EPS guidance for the year ending December 31, 2024 (FY 2024) to approximately $13.93

revised by a later guidance$13.9300receipt →
Superseded · eps guidance fy

Updates FY 2021 EPS guidance to a range of $24.97 to $25.47 on a GAAP basis

revised by a later guidancereceipt →
Superseded · eps guidance fy

Revises FY 2023 EPS guidance to 'at least $26.91' on a GAAP basis

revised by a later guidancereceipt →
Superseded · eps guidance fy

revising GAAP EPS to 'approximately $14.68'

revised by a later guidance$14.6800receipt →
Superseded · eps guidance fy

Updates FY 2025 GAAP EPS guidance to 'approximately $13.77'

revised by a later guidance$13.7700receipt →
Superseded · eps guidance fy

Humana revised its GAAP EPS guidance for the year ending December 31, 2024 (FY 2024) to approximately $12.81

revised by a later guidance$12.8100receipt →
Superseded · eps guidance fy

The company now expects FY 2023 GAAP to be 'at least $27.88'

revised by a later guidancereceipt →

Credibility timeline

MISSED · Feb 21, 2019BEAT · Feb 18, 2021MISSED · Feb 17, 2022MISSED · Feb 16, 2023MISSED · Feb 15, 2024MISSED · Feb 20, 2025MISSED · Feb 19, 2026KEPT · Feb 19, 2026
20192026
Timeline as a list
  • Feb 21, 2019MISSEDGAAP EPS was increased to $13.54 to $13.94
  • Feb 18, 2021BEATnow anticipating GAAP EPS to be in a range of $24.70 to $24.95
  • Feb 17, 2022MISSEDHumana is revising its GAAP EPS guidance range for the year ending December 31, 2021 (FY 2021) to a pproximately $23.67
  • Feb 16, 2023MISSEDUpdates FY 2022 EPS guidance to 'approximately $23.27' on a GAAP basis
  • Feb 15, 2024MISSEDRevises FY 2023 EPS guidance to 'at least $26.31' on a GAAP basis
  • Feb 20, 2025MISSEDUpdates FY 2024 EPS guidance to 'at least $12.89' on a GAAP basis
  • Feb 19, 2026MISSEDUpdates FY 2025 GAAP EPS guidance to 'approximately $12.26'
  • Feb 19, 2026KEPTRaises FY 2025 consolidated revenues guidance to 'at least $128 billion'
8 resolved guidance promises · 32dropped (couldn't be resolved on a consistent basis) · resolver resolver-v3 · score score-v1. Every verdict links to its source filing. Full methodology →